10-13 January 2022
San Francisco
20-22 December 2021
Jerusalem
“Some 70% of antibiotics worldwide are administered to animals, and affected pathogens may later develop antimicrobial resistance and enter the environment, affecting humans,” says David
David Javier Iscovich, Mileutis ceo, In an interview for the Animal Health Innovation Europe conference 2021
Mileutis was selected as an emerging company back in 2016 at the very first Animal Health Innovation Europe event. CEO of Mileutis, David Javier Iscovich,
Mileutis is developing residue-free natural proteins based on early research conducted at Israel’s Agricultural Research Organization (Volcani Center), and at Mileutis. The company is developing
NESS ZIONA, Israel /PRNewswire/ Antimicrobial resistance (AMR), which is mainly caused by antibiotic use, is one of the top 10 global public health threats facing
Raleigh, North Carolina and Ness Ziona, Israel – NovaQuest Capital Management LLC, a leading investor in life sciences and healthcare, announced a $20 million (USD)
